Purification of matrix metalloproteinases by column chromatography

Nature Protocols

Volumn 3, Issue 7, 2008, Pages 1111-1124

  Imai, Kazushi ^a   Okada, Yasunori ^b  

^a NIPPON DENTAL UNIVERSITY   (Japan)

^b KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELLULOSE; COLLAGENASE 3; DIETHYLAMINOETHYL CELLULOSE; GELATIN; GELATINASE A; GELATINASE B; IMMUNOGLOBULIN G; INTERSTITIAL COLLAGENASE; MACROPHAGE ELASTASE; MATRILYSIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 15; MATRIX METALLOPROTEINASE 16; MATRIX METALLOPROTEINASE 17; MATRIX METALLOPROTEINASE 19; MATRIX METALLOPROTEINASE 20; MATRIX METALLOPROTEINASE 26; NEUTROPHIL COLLAGENASE; PROTEINASE; SCLEROPROTEIN; SEPHAROSE; STROMELYSIN; STROMELYSIN 2; STROMELYSIN 3; ZINC;

ANGIOGENESIS; ARTICLE; BIOCHEMISTRY; CANCER CELL; CELL PROLIFERATION; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME PURIFICATION; ENZYME SUBSTRATE; GEL FILTRATION CHROMATOGRAPHY; HISTOGENESIS; HUMAN; HUMAN CELL; IMMUNOAFFINITY CHROMATOGRAPHY; ORGANOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FAMILY; PROTEIN INTERACTION; TIME; TISSUE INJURY;

CHROMATOGRAPHY; DEAE-CELLULOSE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; MATRIX METALLOPROTEINASES; RECOMBINANT PROTEINS;

EID: 50249142459     PISSN: 17542189     EISSN: 17502799     Source Type: Journal    
DOI: 10.1038/nprot.2008.74     Document Type: Article

References (62)

1. Egeblad, M. & Werb, Z. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2, 161-174 (2002).
2. Seiki, M. The cell surface: The stage for matrix metalloproteinase regulation of migration. Curr. Opin. Cell Biol. 14, 624-632 (2002).
3. Visse, R. & Nagase, H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: Structure, function, and biochemistry. Circ. Res. 92, 827-839 (2003).
4. Handsley, M.M. & Edwards, D.R. Metalloproteinases and their inhibitors in tumor angiogenesis. Int. J. Cancer 115, 849-860 (2005).
5. Okada, Y. Proteinases and matrix degradation. In Kelleys Textbook of Rheumatology 7th edition (eds. Harris, E.D. Jr., Budd, R.C., Genovese, M.C., Firestein, G.S. & Sargent J.S.) 63-81 (W.B. Saunders Company, Philadelphia, 2005).
6. Gross, J. & Lapiere, C.M. Collagenolytic activity in amphibian tissues: a tissue culture assay. Proc. Natl. Acad. Sci. USA 48, 1014-1022 (1962).
7. Baker, A.H., Edwards, D.R. & Murphy, G. Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J. Cell Sci. 115, 3719-3727 (2002).
8. Pilcher, B.K. et al. The activity of collagenase-1 is required for keratinocyte migration on a type I collagen matrix. J. Cell Biol. 137, 1445-1457 (1997).
9. Krekoski, C.A., Neubauer, D., Graham, J.B. & Muir, D. Metalloproteinase-dependent predegeneration in vitro enhances axonal regeneration within acellular peripheral nerve grafts. J. Neurosci. 22, 10408-10415 (2002).
10. Fukai, F. et al. Release of biological activities from quiescent fibronectin by a conformational change and limited proteolysis by matrix metalloproteinases. Biochemistry 34, 11453-11459 (1995).
11. Holliday, L.S. et al. Initiation of osteoclast bone resorption by interstitial collagenase. J. Biol. Chem. 272, 22053-22058 (1997).
12. Lochter, A. et al. Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymat conversion and a premalignant phenotype in mammary epithelial cells. J. Cell Biol. 139, 1861-1872 (1997).
13. Hiraoka, N., Allen, E., Apel, I.J., Gyetko, M.R. & Weiss, S.J. Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins. Cell 95, 365-377 (1998).
14. Chun, T.H. et al. A pericellular collagenase directs the 3-dimensional development of white adipose tissue. Cell 125, 577-591 (2006).
15. Fowlkes, J.L., Enghild, J.J., Suzuki, K. & Nagase, H. Matrix metalloproteinases degrade insulin-like growth factor-binding protein-3 in dermal fibroblast cultures. J. Biol. Chem. 269, 25742-25746 (1994).
16. Thrailkill, K.M. et al. Characterization of insulin-like growth factor-binding protein 5-degrading proteases produced throughout murine osteoblast differentiation. Endocrinology 136, 3527-3533 (1995).
17. Whitelock, J.M., Murdoch, A.D., Iozzo, R.V. & Underwood, P.A. The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases. J. Biol. Chem. 271, 10079-10086 (1996).
18. Imai, K., Hiramatsu, A., Fukushima, D., Pierschbacher, M.D. & Okada, Y. Degradation of decorin by matrix metalloproteinases: Identification of the cleavage sites, kinetic analyses and transforming growth factor-beta1 release. Biochem. J. 322, 809-814 (1997).
19. Manes, S. et al. Identification of insulin-like growth factor-binding protein-1 as a potential physiological substrate for human stromelysin-3. J. Biol. Chem. 272, 25706-25712 (1997).
20. Hashimoto, G. et al. Matrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165. J. Biol. Chem. 277, 36288-36295 (2002).
21. Shiomi, T. et al. Pericellular activation of proMMP-7 (promatrilysin-1) through interaction with CD151. Lab. Invest. 85, 1489-1506 (2005).
22. Overall, C.M. & Kleifeld, O. Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. Nat. Rev. Cancer 6, 227-239 (2006).
23. Ito, A. et al. Degradation of interleukin 1 beta by matrix metalloproteinases. J. Biol. Chem. 271, 14657-14660 (1996).
24. Powell, W.C., Fingleton, B., Wilson, C.L., Boothby, M. & Matrisian, L.M. The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis. Curr. Biol. 9, 1441-1447 (1999).
25. McQuibban, G.A. et al. Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. Science 289, 1202-1206 (2000).
26. Noë, V. et al. Release ofan invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. J. Cell Sci. 114, 111-118 (2001).
27. Kajita, M. et al. Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. J. Cell Biol. 153, 893-904 (2001).
28. Sheu, B.C. et al. A novel role of metalloproteinase in cancer-mediated immunosuppression. Cancer Res. 61, 237-242 (2001).
29. Fiore, E., Fusco, C., Romero, P. & Stamenkovic, I. Matrix metalloproteinase 9 (MMP-9/getatinase B) proteolytically cleaves ICAM-1 and participates in tumor cell resistance to natural killer cell-mediated cytotoxicity. Oncogene 21, 5213-5223 (2002).
30. Lynch, C.C. et al. Matrix metalloproteinase 7 mediates mammary epithelial cell tumorigenesis through the ErbB4 receptor. Cancer Res 67, 6760-6767 (2007).
31. Sawey, E.T., Johnson, J.A. & Crawford, H.C. Matrix metalloproteinase 7 controls pancreatic acinar cell transdifferentiation by activating the Notch signaling pathway. Proc Natl. Acad. Sci. USA 104, 19327-19332 (2007).
32. Yu, W.H., Woessner, J.F. Jr., McNeish, J.D. & Stamenkovic, I. CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling. Genes Dev. 16, 307-323 (2002).
33. Labrecque, L. et al. Src-mediated tyrosine phosphorylation of caveolin-1 induces its association with membrane type 1 matrix metalloproteinase. J. Biol. Chem. 279, 52132-52140 (2004).
34. Nisato, R.E. et al. Dissecting the role of matrix metalloproteinases (MMP) and integrin alpha(v)beta3 in angiogenesis in vitro: Absence of hemopexin C domain bioactivity, but membrane-Type 1-MMP and alpha(v)beta3 are critical. Cancer Res. 65, 9377-9387 (2005).
35. Fujita, Y. et al. Tetraspanin CD151 is expressed in osteoarthritic cartilage and is involved in pericellular activation of pro-matrix metalloproteinase 7 in osteoarthritic chondrocytes. Arthritis Rheum 54, 3233-3243 (2006).
36. Okada, Y., Nagase, H. & Harris, E.D. Jr. A metalloproteinase from human rheumatoid synovial fibroblasts that digests connective tissue matrix components. Purification and characterization. J. Biol. Chem. 261, 14245-14255 (1986).
37. Okada, Y., Harris, E.D. Jr. & Nagase, H. The precursor of a metalloendopeptidase from human rheumatoid synovial fibroblasts. Purification and mechanisms of activation by endopeptidases and 4-aminophenylmercuric acetate. Biochem. J. 254, 731-741 (1988).
38. Okada, Y. et al. Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties. Eur. J. Biochem. 194, 721-730 (1990).
39. Okada, Y. et al. Matrix metalloproteinase 9 (92-kDa gelatinase/ type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties. J. Biol. Chem. 267, 21712-21719 (1992).
40. Imai, K. et al. Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2. Cancer Res. 56, 2707-2710 (1996).
41. Ohuchi, E. et al. Membrane type 1 matrix meta [top rotei nase digests interstitial collagens and other extracellular matrix macromolecules. J. Biol. Chem. 272, 2446-2451 (1997).
42. Nakamura, H., Fujii, Y., Ohuchi, E., Yamamoto, E. & Okada, Y. Activation of the precursor of human stromelysin 2 and its interactions with other matrix metalloproteinases. Eur. J. Biochem. 253, 67-75 (1998).
43. Shimada, T. et al. Characterization of a truncated recombinant form of human membrane type 3 matrix metalloproteinase. Eur. J. Biochem. 262, 907-914 (1999).
44. Imai, K. et al. Matrix metalloproteinase 7 (matrilysin) from human rectal carcinoma cells. Activation of the precursor, interaction with other matrix metalloproteinases and enzymic properties. J. Biol. Chem. 270, 6691-6697 (1995).
45. Watanabe, H., Nakanishi, I., Yamashita, K., Hayakawa, T. & Okada, Y. Matrix metalloproteinase-9 (92 kDa gelatinase/type IV collagenase) from U937 monoblastoid cells: Correlation with cellular invasion. J. Cell Sci. 104, 991-999 (1993).
46. Itoh, M. et al. Purification and refolding of recombinant human proMMP-7 (pro-matrilysin) expressed in Escherichia coli and its characterization. J. Biochem. 119, 667-673 (1996).
47. Kinoshita, T. et al. TIMP-2 promotes activation of progelatinase A by membrane-type 1 matrix metalloproteinase immobilized on agarose beads. J. Biol. Chem. 273, 16098-16103 (1998).
48. Conlon, J.M. Purification of naturally occurring peptides by reversed-phase H PLC. Nat. Protoc. 2, 191-197 (2007).
49. Shechter, D., Dormann, H.L., Allis, C.D. & Hake, S.B. Extraction, purification and analysis of histones. Nat. Protoc. 2, 1445-1457 (2007).
50. Shapiro, S.D. et al. Activation of the 92-kDa gelatinase by stromelysin and 4-aminophenylmercuric acetate. Differential processing and stabilization of the carboxyl-terminal domain by tissue inhibitor of metalloproteinases (TIMP). J. Biol. Chem. 270, 6351-6356 (1995).
51. Shipley, J.M. et al. The structural basis for the elastolytic activity of the 92-kDa and 72-kDa gelatinases. Role of the fibronectin type II-like repeats. J. Biol. Chem. 271, 4335-4341 (1996).
52. Stricklin, G.P., Bauer, E.A., Jeffrey, J.J. & Eisen, A.Z. Human skin collagenase: Isolation of precursor and active forms from both fibroblast and organ cultures. Biochemistry 16, 1607-1615 (1977).
53. Harayama, T. et al. Shedding of membrane type 1 matrix metalloproteinase in a human breast carcinoma cell line. Jpn. J. Cancer Res. 90, 942-950 (1999).
54. Templeton, N.S. et al. Cloning and characterization of human tumor cell interstitial collagenase. Cancer Res. 50, 5431-5437 (1990).
55. Muir, D. & Manthorpe, M. Stromelysin generates a fibronectin fragment that inhibits Schwann cell proliferation. J. Cell Biol. 116, 177-185 (1992).
56. Chevallet, M., Luche, S. & Rabilloud, T. Silver staining of proteins in polyacrylamide gets. Nat. Protoc. 1, 1852-1858 (2006).
57. Moutsiakis, D., Mancuso, P., Krutzsch, H., Stetter-Stevenson, W. & Zucker, S. Characterization of metalloproteinases and tissue inhibitors of metalloproteinases in human plasma. Connect. Tissue Res. 28 213-230 (1992).
58. Birkedal-Hansen, H. Catabolism and turnover of collagens: Collagenases. Methods Enzymol. 144, 140-171 (1987).
59. Nagase, H. Human stromelysins 1 and 2. Methods Enzymol. 248, 449-470 (1995).
60. Nakamura, H. et al. Brevican is degraded by matrix metalloproteinases and aggrecanase-1 (ADAMTS4) at different sites. J. Biol. Chem. 275, 38885-38890 (2000).
61. Ward, R.V., Hembry, R.M., Reynolds, J.J. & Murphy, G. The purification of tissue inhibitor of metalloproteinases-2 from its 72 kDa progelatinase complex. Demonstration of the biochemical similarities of tissue inhibitor of metalloproteinases-2 and tissue inhibitor of metalloproteinases- 1. Biochem. J. 278, 179-187 (1991).
62. Rozanov, D.V. & Strongin, A.Y. Membrane type-1 matrix metalloproteinase functions as a proprotein self- convertase. Expression of the latent zymogen in Pichia pastoris, autolytic activation, and the peptide sequence of the cleavage forms. J. Biol. Chem. 278, 8257-8260 (2003).